These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4045046)

  • 1. High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
    Hillis LD; Borer J; Braunwald E; Chesebro JH; Cohen LS; Dalen J; Dodge HT; Francis CK; Knatterud G; Ludbrook P
    J Am Coll Cardiol; 1985 Nov; 6(5):957-62. PubMed ID: 4045046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term infarct vessel patency with aspirin and dipyridamole started 24 to 36 hours after intravenous streptokinase.
    Hays LJ; Beller GA; Moore CA; Burwell LR; Craddock GB; Gascho JA; Smucker ML; Tedesco C; Nygaard TW
    Am Heart J; 1988 Apr; 115(4):717-21. PubMed ID: 3354400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ
    Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.
    MacLennan BA; McMaster A; Webb SW; Khan MM; Adgey AA
    Br Heart J; 1986 Mar; 55(3):231-9. PubMed ID: 3954907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ
    Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P; Pérez-Villa F; Waters D; Lespérance J; Shabani F; Bonan R
    Circulation; 1995 Apr; 91(8):2132-9. PubMed ID: 7697841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody.
    Lew AS; Neer T; Rodriguez L; Geft IL; Shah PK; Ganz W
    J Am Coll Cardiol; 1984 Jul; 4(1):183-5. PubMed ID: 6736447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do different doses of intravenous streptokinase alter the frequency of coronary reperfusion in acute myocardial infarction?
    Gottlich CM; Cooper B; Schumacher JR; Hillis LD
    Am J Cardiol; 1988 Nov; 62(13):843-6. PubMed ID: 3177232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
    White HD; Aylward PE; Frey MJ; Adgey AA; Nair R; Hillis WS; Shalev Y; Brown MA; French JK; Collins R; Maraganore J; Adelman B
    Circulation; 1997 Oct; 96(7):2155-61. PubMed ID: 9337184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators.
    Fung AY; Lorch G; Cambier PA; Hansen D; Titus BG; Martin JS; Lee JJ; Every NR; Hallstrom AP; Stock-Novack D; Scherer J; Weaver WD
    Am Heart J; 1999 Oct; 138(4 Pt 1):696-704. PubMed ID: 10502216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction.
    Olson HG; Butman SM; Piters KM; Gardin JM; Lyons KP; Jones L; Chilazi G; Kumar KL; Colombo A
    Am Heart J; 1986 Jun; 111(6):1021-9. PubMed ID: 3521245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction.
    Lew AS; Berberian L; Cercek B; Lee S; Shah PK; Ganz W
    J Am Coll Cardiol; 1986 Jun; 7(6):1320-4. PubMed ID: 3711489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report.
    Kennedy JW; Ritchie JL; Davis KB; Stadius ML; Maynard C; Fritz JK
    N Engl J Med; 1985 Apr; 312(17):1073-8. PubMed ID: 3982468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction.
    Kasper W; Erbel R; Meinertz T; Drexler M; Rückel A; Pop T; Prellwitz W; Meyer J
    J Am Coll Cardiol; 1984 Aug; 4(2):357-63. PubMed ID: 6429226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.